119 related articles for article (PubMed ID: 36863698)
1. De novo mutations disturb early brain development more frequently than common variants in schizophrenia.
Itai T; Jia P; Dai Y; Chen J; Chen X; Zhao Z
Am J Med Genet B Neuropsychiatr Genet; 2023 Apr; 192(3-4):62-70. PubMed ID: 36863698
[TBL] [Abstract][Full Text] [Related]
2. Genes regulated by BCL11B during T-cell development are enriched for de novo mutations found in schizophrenia patients.
Fahey L; Donohoe G; Broin PÓ; Morris DW
Am J Med Genet B Neuropsychiatr Genet; 2020 Sep; 183(6):370-379. PubMed ID: 32729240
[TBL] [Abstract][Full Text] [Related]
3. Identification of de novo mutations in prenatal neurodevelopment-associated genes in schizophrenia in two Han Chinese patient-sibling family-based cohorts.
Jiang S; Zhou D; Wang YY; Jia P; Wan C; Li X; He G; Cao D; Jiang X; Kendler KS; Tsuang M; Mize T; Wu JS; Lu Y; He L; Chen J; Zhao Z; Chen X
Transl Psychiatry; 2020 Sep; 10(1):307. PubMed ID: 32873781
[TBL] [Abstract][Full Text] [Related]
4. Exome sequencing in schizophrenia-affected parent-offspring trios reveals risk conferred by protein-coding de novo mutations.
Howrigan DP; Rose SA; Samocha KE; Fromer M; Cerrato F; Chen WJ; Churchhouse C; Chambert K; Chandler SD; Daly MJ; Dumont A; Genovese G; Hwu HG; Laird N; Kosmicki JA; Moran JL; Roe C; Singh T; Wang SH; Faraone SV; Glatt SJ; McCarroll SA; Tsuang M; Neale BM
Nat Neurosci; 2020 Feb; 23(2):185-193. PubMed ID: 31932770
[TBL] [Abstract][Full Text] [Related]
5. Direct measure of the de novo mutation rate in autism and schizophrenia cohorts.
Awadalla P; Gauthier J; Myers RA; Casals F; Hamdan FF; Griffing AR; Côté M; Henrion E; Spiegelman D; Tarabeux J; Piton A; Yang Y; Boyko A; Bustamante C; Xiong L; Rapoport JL; Addington AM; DeLisi JL; Krebs MO; Joober R; Millet B; Fombonne E; Mottron L; Zilversmit M; Keebler J; Daoud H; Marineau C; Roy-Gagnon MH; Dubé MP; Eyre-Walker A; Drapeau P; Stone EA; Lafrenière RG; Rouleau GA
Am J Hum Genet; 2010 Sep; 87(3):316-24. PubMed ID: 20797689
[TBL] [Abstract][Full Text] [Related]
6. Integrated Bayesian analysis of rare exonic variants to identify risk genes for schizophrenia and neurodevelopmental disorders.
Nguyen HT; Bryois J; Kim A; Dobbyn A; Huckins LM; Munoz-Manchado AB; Ruderfer DM; Genovese G; Fromer M; Xu X; Pinto D; Linnarsson S; Verhage M; Smit AB; Hjerling-Leffler J; Buxbaum JD; Hultman C; Sklar P; Purcell SM; Lage K; He X; Sullivan PF; Stahl EA
Genome Med; 2017 Dec; 9(1):114. PubMed ID: 29262854
[TBL] [Abstract][Full Text] [Related]
7. Analysis of GWAS-Derived Schizophrenia Genes for Links to Ischemia-Hypoxia Response of the Brain.
Schmidt-Kastner R; Guloksuz S; Kietzmann T; van Os J; Rutten BPF
Front Psychiatry; 2020; 11():393. PubMed ID: 32477182
[TBL] [Abstract][Full Text] [Related]
8. Impact of schizophrenia GWAS loci converge onto distinct pathways in cortical interneurons vs glutamatergic neurons during development.
Liu D; Zinski A; Mishra A; Noh H; Park GH; Qin Y; Olorife O; Park JM; Abani CP; Park JS; Fung J; Sawaqed F; Coyle JT; Stahl E; Bendl J; Fullard JF; Roussos P; Zhang X; Stanton PK; Yin C; Huang W; Kim HY; Won H; Cho JH; Chung S
Mol Psychiatry; 2022 Oct; 27(10):4218-4233. PubMed ID: 35701597
[TBL] [Abstract][Full Text] [Related]
9. Varying Intolerance of Gene Pathways to Mutational Classes Explain Genetic Convergence across Neuropsychiatric Disorders.
Shohat S; Ben-David E; Shifman S
Cell Rep; 2017 Feb; 18(9):2217-2227. PubMed ID: 28249166
[TBL] [Abstract][Full Text] [Related]
10. A novel
Singh AK; Viviano S; Allington G; McGee S; Kiziltug E; Mekbib KY; Shohfi JP; Duy PQ; DeSpenza T; Furey CG; Reeves BC; Smith H; Ma S; Sousa AMM; Cherskov A; Allocco A; Nelson-Williams C; Haider S; Rizvi SRA; Alper SL; Sestan N; Shimelis H; Walsh LK; Lifton RP; Moreno-De-Luca A; Jin SC; Kruszka P; Deniz E; Kahle KT
medRxiv; 2023 Mar; ():. PubMed ID: 36993720
[TBL] [Abstract][Full Text] [Related]
11. Implications of de novo mutations in guiding drug discovery: A study of four neuropsychiatric disorders.
So HC; Wong YH
J Psychiatr Res; 2019 Mar; 110():83-92. PubMed ID: 30597425
[TBL] [Abstract][Full Text] [Related]
12.
Luo T; Li K; Ling Z; Zhao G; Li B; Wang Z; Wang X; Han Y; Xia L; Zhang Y; Zhou Q; Fang Z; Wang Y; Chen Q; Zhou X; Pan H; Zhao Y; Wang Y; Dong L; Huang Y; Hu Z; Pan Q; Xia K; Li J
Comput Struct Biotechnol J; 2021; 19():1414-1422. PubMed ID: 33777337
[TBL] [Abstract][Full Text] [Related]
13. RNA metabolism and dysmyelination in schizophrenia.
McInnes LA; Lauriat TL
Neurosci Biobehav Rev; 2006; 30(4):551-61. PubMed ID: 16445981
[TBL] [Abstract][Full Text] [Related]
14. Probing the biological consequences of a previously undescribed de novo mutation of ZMYND11 in a schizophrenia patient by CRISPR genome editing and induced pluripotent stem cell based in vitro disease-modeling.
Tordai C; Hathy E; Gyergyák H; Vincze K; Baradits M; Koller J; Póti Á; Jezsó B; Homolya L; Molnár MJ; Nagy L; Szüts D; Apáti Á; Réthelyi JM
Schizophr Res; 2024 Jan; ():. PubMed ID: 38290943
[TBL] [Abstract][Full Text] [Related]
15. De novo mutations identified by exome sequencing implicate rare missense variants in SLC6A1 in schizophrenia.
Rees E; Han J; Morgan J; Carrera N; Escott-Price V; Pocklington AJ; Duffield M; Hall LS; Legge SE; Pardiñas AF; Richards AL; Roth J; Lezheiko T; Kondratyev N; Kaleda V; Golimbet V; Parellada M; González-Peñas J; Arango C; ; Gawlik M; Kirov G; Walters JTR; Holmans P; O'Donovan MC; Owen MJ
Nat Neurosci; 2020 Feb; 23(2):179-184. PubMed ID: 31932766
[TBL] [Abstract][Full Text] [Related]
16. Cross-Disorder Analysis of De Novo Mutations in Neuropsychiatric Disorders.
Li K; Fang Z; Zhao G; Li B; Chen C; Xia L; Wang L; Luo T; Wang X; Wang Z; Zhang Y; Jiang Y; Pan Q; Hu Z; Guo H; Tang B; Liu C; Sun Z; Xia K; Li J
J Autism Dev Disord; 2022 Mar; 52(3):1299-1313. PubMed ID: 33970367
[TBL] [Abstract][Full Text] [Related]
17. Exome sequencing in 53 sporadic cases of schizophrenia identifies 18 putative candidate genes.
Guipponi M; Santoni FA; Setola V; Gehrig C; Rotharmel M; Cuenca M; Guillin O; Dikeos D; Georgantopoulos G; Papadimitriou G; Curtis L; Méary A; Schürhoff F; Jamain S; Avramopoulos D; Leboyer M; Rujescu D; Pulver A; Campion D; Siderovski DP; Antonarakis SE
PLoS One; 2014; 9(11):e112745. PubMed ID: 25420024
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of rare NRXN1 variants identified in autism spectrum disorders and schizophrenia.
Ishizuka K; Yoshida T; Kawabata T; Imai A; Mori H; Kimura H; Inada T; Okahisa Y; Egawa J; Usami M; Kushima I; Morikawa M; Okada T; Ikeda M; Branko A; Mori D; Someya T; Iwata N; Ozaki N
J Neurodev Disord; 2020 Sep; 12(1):25. PubMed ID: 32942984
[TBL] [Abstract][Full Text] [Related]
19. De novo missense variants disrupting protein-protein interactions affect risk for autism through gene co-expression and protein networks in neuronal cell types.
Chen S; Wang J; Cicek E; Roeder K; Yu H; Devlin B
Mol Autism; 2020 Oct; 11(1):76. PubMed ID: 33032641
[TBL] [Abstract][Full Text] [Related]
20. Prioritization of schizophrenia risk genes from GWAS results by integrating multi-omics data.
He D; Fan C; Qi M; Yang Y; Cooper DN; Zhao H
Transl Psychiatry; 2021 Mar; 11(1):175. PubMed ID: 33731678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
